Merck in Late-Stage Talks to Acquire Prometheus Biosciences

image
Photo: BRENDAN MCDERMID/REUTERS

Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a move that could give the big drugmaker promising immune disease treatments.

A deal for Prometheus could be announced as soon as Sunday, the people said, cautioning the talks could still fall apart.

What's News

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue reading your article with
a WSJ subscription

Subscribe Now

Already a subscriber? Sign In

Sponsored Offers
  • Walmart:
    20% off your order with Walmart promo code
  • Saks Fifth Avenue:
    Saks Fifth Avenue promo code: 20% off first order
  • Kohl's:
    Save 15% on orders of $100+ with Kohl's coupon
  • adidas:
    adidas Promo Code - Up to 50% Off 3-Stripe Favorites
  • Nike:
    60% off running shoes and apparel at Nike without a promo code
  • American Eagle Outfitters:
    15% off American Eagle promo code